Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-26-004843
Filing Date
2026-08-06
Accepted
2026-08-06 17:48:00
Documents
3
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9854
2 p15043430ex_a.htm EX-99 9593
3 p15043430ex_b.htm EX-99 1067
  Complete submission text file 0000919574-26-004843.txt   22294
Mailing Address 11 E 26TH STREET 16TH FLOOR NEW YORK NY 10010
Business Address 11 E 26TH STREET 16TH FLOOR NEW YORK NY 10010 2127025205
MONTANOVA CAPITAL, LLC (Filed by) CIK: 0001569064 (see all company filings)

EIN.: 453704500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Subject) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90574 | Film No.: 261250649
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)